| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhang,De-Ren | Chairman | 7.12% | |
| Zhang,De-Xiong | Director | 7.56% | |
| Zhang,De-Sheng | Director | 6.40% | |
| Wu,Xiao-Yan | Director | 0.00% | |
| Zhuang,Bi-Yang | Independent Director | 0.00% | |
| Zhan,Jin-Yi | Independent Director | 0.00% | |
| Wu,Jian-Xun | Independent Director | 0.00% | |
| Zhang,Jin-Cheng | Independent Director | 0.00% |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 2,544,275 | 9,525,927 | 9,354,380 |
| Operating cost | 1,873,124 | 7,051,865 | 7,014,741 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 671,151 | 2,474,062 | 2,339,639 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 671,151 | 2,474,062 | 2,339,639 |
| Operating expenses | 354,036 | 1,482,106 | 1,394,865 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 317,115 | 991,956 | 944,774 |
| Non-operating income and expenses | 14,501 | 115,236 | 97,926 |
| Net profit (loss) before tax | 331,616 | 1,107,192 | 1,042,700 |
| Income tax expense (benefits) | 72,332 | 251,139 | 211,462 |
| Net profit (loss) of ongoing business for the current period | 259,284 | 856,053 | 831,238 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 259,284 | 856,053 | 831,238 |
| Other comprehensive profit (loss), net | 59,401 | 186,682 | -49,471 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 318,685 | 1,042,735 | 781,767 |
| Net profit (loss) attributable to owners of parent company | 259,284 | 856,053 | 831,238 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 318,685 | 1,042,735 | 781,767 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 1 | 5 | 5 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 322,565 | 593,218 | 1,578,264 |
| Net cash inflows (outflows) from investing activities | -202,347 | -838,121 | -519,784 |
| Net cash inflow (outflow) from financing activities | -3,185 | -580,640 | -684,964 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 31,475 | 107,382 | -33,038 |
| Increase (decrease) in cash and cash equivalents in the current period | 148,508 | -718,161 | 340,478 |
| Beginning balance of cash and cash equivalents | 1,126,750 | 1,844,911 | 1,504,433 |
| Ending balance of cash and cash equivalents | 1,275,258 | 1,126,750 | 1,844,911 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 8,094,496 | 7,858,534 | 7,616,920 |
| Non-current asset | 4,046,841 | 3,988,110 | 3,941,384 |
| Total asset | 12,141,337 | 11,846,644 | 11,558,304 |
| Current liability | 1,450,832 | 1,468,820 | 1,622,652 |
| Non-current liability | 107,626 | 113,630 | 147,636 |
| Total liability | 1,558,458 | 1,582,450 | 1,770,288 |
| share capital | 1,620,000 | 1,620,000 | 1,620,000 |
| Equity - secruity token | - | - | - |
| capital reserve | 109,873 | 109,873 | 109,430 |
| retained earning | 8,874,483 | 8,615,199 | 8,301,528 |
| Other equity | -21,477 | -80,878 | -242,942 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 10,582,879 | 10,264,194 | 9,788,016 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 10,582,879 | 10,264,194 | 9,788,016 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 65 | 63 | 60 |
Others
2004, 2011, 2017, 2018
Pay for pension
2003
Auction collateral
2022
Pay for the project
2013, 2019
Division of common property
2020, 2023
Confirmation of the non-existence of promissory note
2014
Confirmation of the existence of employment relationship, etc
2021
Others
2001, 2003, 2020
Payment order
2007, 2008, 2009, 2013, 2014, 2015, 2019, 2020, 2021, 2022, 2023
Payment, etc.
2005
Return deposit
2007, 2009, 2011
Exercise rights
2015
Pay for pension
2004
Fair Trading Act
2007, 2008, 2009, 2011
Pay for the goods
2000, 2001, 2002, 2003, 2015, 2016, 2022
Auction collateral
2014, 2022
Pay for the project
2004, 2009, 2014
Invalidating Judgment
2005, 2006, 2010, 2020, 2022
Promissory note ruling
2014
Compensation for damage
2015, 2016
Invention patent filing
2010, 2011
Return security deposit
2008, 2016
Return rental property, etc.
2014
Request for damage compensation
2023
Pay the buying and selling price
2014
Petition filed for public summons
2010, 2018, 2020, 2022
Promissory note ruling enforcement
2011
Revocation of Arbitration Judgment
2002, 2003
Confirmation of the existence of debt
2007, 2009
Exercising rights within a time limit
2009
Request for infringement compensation
2024
